NASDAQ · Biotechnology

NGEN (NGEN) Stock

$1.59 -1.24% NASDAQ: NGEN Healthcare

Valuation

MetricValue
Price$1.59
Market Cap$130.69M
P/E Ratio-6.05
P/B Ratio99.54
P/S Ratio0.00
EPS (TTM)$-0.61
52-Week High$6.30
52-Week Low$1.59
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-1466.67%
ROA-191.30%
ROCE-833.33%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio1.15

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-10.0M$-17.0M$-13.0M$-17.0M$-25.0M
Net Profit$-10.0M$-15.0M$-17.0M$-17.0M$-44.0M
EPS$-0.26$-0.29$-0.28$-0.25$-0.61
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$14.0M$18.0M$10.0M$14.0M$23.0M
Total Liabilities$1.0M$8.0M$12.0M$12.0M$20.0M
Cash$13.0M$17.0M$9.0M$12.0M$22.0M
Borrowings$0$0$0$0$0

Latest News

TD Cowen Initiates NervGen Pharma at Buy MT Newswires · Jun 11, 2026 NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study GlobeNewswire · May 26, 2026 Top Premarket Decliners MT Newswires · May 22, 2026 NervGen Pharma Prices $60 Million Share Offering MT Newswires · May 22, 2026 NervGen Announces Pricing of US$60.0 Million Public Offering of Securities GlobeNewswire · May 22, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-7.0M$-13.0M$-9.0M$-12.0M$-19.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$-1.0M
Net Cash Flow$9.0M$3.0M$-8.0M$3.0M$5.0M
Free Cash Flow$-7.0M$-13.0M$-9.0M$-12.0M$-19.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-4.78%
Quick Ratio1.16
Interest Coverage—
Return 1Y-42.57%
Return 3Y32.82%
Return 5Y24.02%

Ownership

Insiders Held20.33%
Institutions Held2.07%
Institutions Float Held2.60%
Institutional HolderSharesReport Date
Pfg Investments, LLC 201,0002026-03-31
Marshall Wace LLP200,3592026-03-31
Bank of America Corporation200,6562026-03-31
Royal Bank of Canada171,9612026-03-31
Integrated Wealth Concepts LLC86,8152026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About NGEN

NGEN is led by CEO Adam H. Rogers, employs 7 people, headquartered in CA, publicly traded since 2021.

NGEN stock trades at $1.59 with a market capitalization of $130.69M. The stock is valued at a price-to-earnings (P/E) ratio of -6.05, price-to-book of 99.54, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.59 and $6.30, and currently trades 74.8% below its 52-week high.

On profitability, NGEN generates a return on equity (ROE) of -1466.67%, return on capital employed of -833.33%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides